Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs
Cardiovascular Therapeutics · 2024
DOI: 10.1155/2024/4778469 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cardiovascular Therapeutics, 2024. Verfasst von Jochen Pfeifer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology Saarland University Medical Center, Homburg 66421, Germany. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Cardiac Catheterization, Heart Defects, Congenital. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität des Saarlandes, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Objective
The objective of this study is to evaluate the clinical application and primary outcome of transcatheter embolization using Amplatzer™ Vascular Plug (AVP) Type 2 and Type 4 in different congenital cardiovascular malformations.
Design
This is a single‐center retrospective observational cohort study.
Methods
We analyzed clinical and imaging data of 36 patients retrospectively who received transcatheter embolizations of the following malformations using AVP: systemic‐to‐pulmonary collateral arteries (SPCA), patent ductus arteriosus (PDA), ventricular septal defects (VSD), and aberrant pulmonary sequestration arteries (PSA). We included all patients treated in our institution from January 2010 to July 2023.
Results
In 36 patients (median age 40.0 months, range 0.5 months–42.0 years; 56.8% male), 44 AVPs were implanted in 37 procedures. The target lesions were SPCA in n = 15 procedures, PDA in n = 9, VSD in n = 9, and PSA in n = 4. Thirty‐four AVP Type 2 and 10 AVP Type 4 were applied, the latter only in SPCA and PSA. SPCA was most common in complex congenital heart disease with univentricular physiology (75.0%). VSD were associated with additional cardiac malformations in 33.3%, PDA were associated with prematurity (55.6%), and all pulmonary sequestrations occurred in scimitar syndrome. Primary total or subtotal occlusion succeeded in n 38/44 (86.3%). For residual PDA, an additional occluder was implanted in one patient. In one case, pulmonary sequestration had to be treated surgically. One premature infant with PDA closure sustained a relevant obstruction of the left pulmonary artery by the outer AVP disc which required surgical correction 4 months later.
Conclusion
Embolization using AVP is a suitable approach for closure of various cardiovascular malformations with a high primary success rate and low complication rate. It should be considered in treatment of different irregular vessel anomalies and in selected VSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatric Cardiology Saarland University Medical Center, Homburg 66421, Germany.
- Clinic for Diagnostic and Interventional Radiology Saarland University Medical Center, Homburg 66421, Germany.
ORCID-Profile: Jochen Pfeifer
Förderung
- Universität des Saarlandes
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Pfeifer, J., Gheibeh, A., Fries, P., Poryo, M., Rentzsch, A., & Abdul-Khaliq, H. (2024). Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs. Cardiovascular Therapeutics. https://doi.org/10.1155/2024/4778469
Vancouver
Pfeifer J, Gheibeh A, Fries P, Poryo M, Rentzsch A, Abdul-Khaliq H. Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs. Cardiovascular Therapeutics. 2024. doi:10.1155/2024/4778469
BibTeX
@article{Pfeifer2024,
author = {Pfeifer, Jochen and Gheibeh, Anas and Fries, Peter and Poryo, Martin and Rentzsch, Axel and Abdul-Khaliq, Hashim},
title = {Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs},
journal = {Cardiovascular Therapeutics},
year = {2024},
doi = {10.1155/2024/4778469}
}
EUVIMED